Biomaterials · 2018 · 47 citations · 30 references
PharmacyBiochemistryMolecular BiologyDrug DeliveryGene DeliveryNucleic Acid ChemistryGene Delivery VectorsIn Vivo Gene DeliveryLipid-based Drug Delivery SystemsNucleic Acid DeliveryOligonucleotide DeliveryPlasmid Dna DeliveryDna NanocarriersGene Delivery BiomaterialsLipid-based VectorsNucleic Acid Delivery SystemsNucleic Acid EncapsulationNucleic Acid TherapeuticsNucleoside AnalogsTransfection Reagents
Lipid derivatives of nucleoside analogs have been highlighted for their potential for effective gene delivery. A novel class of nucleobase-lipids are rationally designed and readily synthesized, comprising thymine/cytosine, an ester/amide linker and an oleyl lipid. The diversity of four nucleobase-lipids termed DXBAs (DOTA, DNTA, DOCA and DNCA) is investigated. Besides, DNCA is demonstrated to be an effective neutral transfection material for nucleic acid delivery, which enbles to bind to oligonucleotides via H-bonding and π-π stacking with reduced toxicity in vitro and in vivo. Several kinds of nucleic acid drugs including aptamer, ssRNA, antisense oligonucleotide, and plasmid DNAs can be delivered by DXBAs, especially DNCA. In particular, G4-aptamer AS1411 encapsulated by DNCA exhibits cellular uptake enhancement, lysosome degradation reduction, cell apoptosis promotion, cell cycle phase alteration in vitro and duration prolongation in vivo, resulting in significant anti-proliferative activity. Our results demonstrate that DNCA is a promising transfection agent for G4-aptamers and exhibites bright application prospects in the permeation improvement of single-stranded oligonucleotides or plasmid DNAs.
30
AS1411-conjugated gold nanospheres and their potential for breast cancer therapy
Mohammad Tariq Malik, Martin G. O’Toole, Lavona Casson et al. · Oncotarget · 2015 · 114 citations · Full text